Pharmacy Practice and NAPLEX Review Flashcards

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/89

flashcard set

Earn XP

Description and Tags

Collection of flashcards for pharmacy students based on nonsterile compounding, toxicology, ethics, cardiology, oncology, and pharmacotherapy notes.

Last updated 4:30 PM on 7/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

90 Terms

1
New cards

Master Formulation Record

A document for a specific preparation, such as the Lidocaine, Benzocaine & Tetracaine Gel used as a topical anesthetic for superficial surgical procedures and laser therapy.

2
New cards

Comminution

The technique used in step 1 of the compounding instructions to grind lidocaine, benzocaine, and tetracaine powders.

3
New cards

Trituration

The method described in step 4 to prepare PLO gel by mixing the organic and aqueous phases.

4
New cards

Geometric dilution

The technique used in step 3 to incorporate powders into a mixture to ensure uniform distribution.

5
New cards

NAPQI

The toxic metabolite produced in the metabolic pathway of acetaminophen.

6
New cards

CYP450 2E1

The specific metabolic pathway/enzyme responsible for the production of the toxic metabolite NAPQI.

7
New cards

Autonomy

The medical ethics principle that addresses informed consent by respecting an individual's right to make decisions that align with their values.

8
New cards

Beneficence

The ethical principle of intending to do good and maximize benefit for the patient.

9
New cards

Justice

The ethical principle that refers to treating people fairly and without discrimination, often focused on distribution of healthcare resources.

10
New cards

Nonmaleficence

The ethical principle of choosing actions that do not cause harm, such as avoiding an unnecessary procedure.

11
New cards

Informed Consent

The process of fully educating a patient on the nature, alternatives, risks, and benefits of a medical intervention.

12
New cards

HIPAA

The Health Insurance Portability and Accountability Act, a federal law that aims to protect patient privacy and confidentiality.

13
New cards

Koplik spots

Small, white spots located on the inside of a daughter's cheeks, which are a characteristic sign of Measles.

14
New cards

Measles

A childhood disease presenting with a temperature of 102.4F102.4^{\circ}F, a rash covering the entire body, and Koplik spots.

15
New cards

Inhaled SABAs

Short-acting beta-2 agonists, such as Albuterol and Levalbuterol, used for as-needed symptom relief in asthma.

16
New cards

Albuterol MOA

Binding to and stimulating beta-2 adrenergic receptors in the lungs, resulting in bronchial smooth muscle relaxation and bronchodilation.

17
New cards

Levalbuterol

The R-isomer of albuterol that may be considered in patients who are unable to tolerate albuterol due to adverse effects like palpitations.

18
New cards

SABA Adverse Effects

Nervousness, tremor, tachycardia, palpitations, cough, and hypokalemia.

19
New cards

Hyperkalemia treatment

Albuterol is used to treat this condition because it shifts potassium into cells by increasing Na+/K+ATPaseNa^+/K^+-ATPase activity.

20
New cards

Vaccine Information Statements (VIS)

CDC-developed documents required to be given to patients prior to every dose of a vaccine, listing benefits, risks, and alternatives.

21
New cards

Flolan

A prostacyclin analogue whose primary indication is the treatment of pulmonary arterial hypertension (PAHPAH).

22
New cards

CHA2DS2-VASc

A scoring system used for stroke risk in nonvalvular atrial fibrillation to determine the need for antithrombotic therapy.

23
New cards

DOACs

Direct-acting oral anticoagulants such as apixaban, edoxaban, rivaroxaban, and dabigatran, which are preferred over warfarin.

24
New cards

S2 (CHA2DS2-VASc)

A component of the stroke risk score referring to prior stroke, TIATIA, or thromboembolism, weighted with 22 points.

25
New cards

A2 (CHA2DS2-VASc)

A component of the stroke risk score referring to Age 75\ge 75, weighted with 22 points.

26
New cards

ISMP

The Institute for Safe Medication Practices, which maintains a list of look-alike and sound-alike (LASALASA) drug names.

27
New cards

Tall man lettering

The use of bolded, uppercase letters to draw attention to differences in drug names, such as DOBUTamineDOBUTamine and DOPamineDOPamine.

28
New cards

Barcode scanning

A method to prevent medication errors by scanning the patient identification bracelet and medication barcode before administration.

29
New cards

Alkylating agents

A class of chemotherapy represented by Cyclophosphamide, which inhibits DNA and protein synthesis and is cell cycle nonspecific.

30
New cards

Anthracyclines

A class of chemotherapy represented by Doxorubicin, which binds DNA to inhibit synthesis and repair via topoisomerase II inhibition.

31
New cards

Folate antimetabolites

A class of chemotherapy represented by Methotrexate, which prevents purine and pyrimidine production in the S phase.

32
New cards

Vinca alkaloids

A class of chemotherapy represented by Vincristine, which inhibits microtubule formation in the M phase.

33
New cards

Live vaccine separation

The requirement that MMRMMR and varicella vaccines be administered at least 3113-11 months after an antibody-containing product.

34
New cards

Oxytrol patch

A transdermal formulation for urinary incontinence that should be changed twice weekly.

35
New cards

Parkinson disease psychosis

Psychotic symptoms such as delusions and visual hallucinations triggered by medications that increase dopamine activity.

36
New cards

Levodopa

A component of Sinemet that acts as a prodrug of dopamine and carries a risk of medication-induced psychosis.

37
New cards

Methotrexate Adverse Effects

Hepatotoxicity, myelosuppression, and mucositis.

38
New cards

Mile's Solution

A magic mouthwash compounded preparation containing lidocaine, diphenhydramine, hydrocortisone, tetracycline, and nystatin.

39
New cards

 Mile's Solution BUD

The beyond-use date for this water-containing oral preparation is 1414 days.

40
New cards

Enoxaparin

The preferred treatment for a pregnant female diagnosed with a right lower extremity venous thromboembolism.

41
New cards

Mucinex D

An OTC cough and cold product that contains a decongestant (pseudoephedrine).

42
New cards

Relative Risk (RR)

The ratio of the risk in the treated group compared to the risk in the control group.

43
New cards

Absolute Risk Reduction (ARR)

The absolute difference in risk between groups, calculated as RiskcontrolRisktreatment\text{Risk}_{control} - \text{Risk}_{treatment}.

44
New cards

Alpha (α\alpha)

The predetermined significance level for endpoints, which in the provided biostatistics study was set at 0.030.03.

45
New cards

Student t-test

An appropriate statistical test used to evaluate between-group differences for continuous variables like Age.

46
New cards

Acute ischemic stroke

A condition managed with reperfusion therapy using IV alteplase if the patient presents within 4.54.5 hours of symptom onset.

47
New cards

Intravenous alteplase

A fibrinolytic indicated for ischemic stroke that must be preceded by a CT scan to rule out intracranial hemorrhage.

48
New cards

Oral nimodipine

A calcium channel blocker indicated only to improve outcomes associated with subarachnoid hemorrhage by preventing vasospasm.

49
New cards

Graves' disease

An autoimmune condition that causes overproduction of thyroid hormones (T3T3, T4T4).

50
New cards

Propylthiouracil (PTU)

The preferred treatment for hyperthyroidism during the first trimester of pregnancy.

51
New cards

Methimazole

The preferred treatment for Graves' disease except during the first trimester of pregnancy or thyroid storm.

52
New cards

Motion sickness treatment

Adult options include Transderm-Scop, Dimenhydrinate, and Meclizine.

53
New cards

Nonsevere inpatient CAP

Community-acquired pneumonia treated with a beta-lactam plus a macrolide or doxycycline.

54
New cards

Prolonged QTc in CAP

A condition (where QTc>440msecQTc > 440\,msec) that makes ceftriaxone plus doxycycline the safest treatment option to avoid macrolides and fluoroquinolones.

55
New cards

Extended-interval dosing

Aminoglycoside dosing using higher doses (e.g., 7mg/kg7\,mg/kg) less often, monitored by a random level compared to a nomogram.

56
New cards

Hartford dosing nomogram

A graph plotted using a random gentamicin level drawn 6146-14 hours after the start of infusion to determine dosing frequency.

57
New cards

Traditional aminoglycoside dosing

Dosing involving smaller doses (1.52.5mg/kg1.5-2.5\,mg/kg) monitored with peaks and troughs.

58
New cards

Statin-associated muscle symptoms

Adverse effects that may require discontinuing statin therapy and starting ezetimibe.

59
New cards

Nitroglycerin SL counseling

One tablet should be allowed to dissolve under the tongue every 55 minutes at the onset of chest pain, up to 33 doses.

60
New cards

Nitroglycerin SL storage

Must be stored at room temperature in the original amber glass vial with the lid closed tightly.

61
New cards

Nitroglycerin SL tablet

A short-acting nitrate used for acute chest pain relief by vasodilating coronary arteries and peripheral veins.

62
New cards

Nitrate-free interval

A period of at least 101210-12 hours required daily to decrease tolerance to long-acting nitrates.

63
New cards

Allopurinol

A xanthine oxidase inhibitor used for urate-lowering therapy that can cause hypersensitivity reactions like severe rash (SJS/TENSJS/TEN).

64
New cards

HLA-B*5801

A genetic marker that should be tested in high-risk patients before starting allopurinol to avoid severe cutaneous reactions.

65
New cards

Pegloticase

A recombinant uricase urate-lowering therapy that can cause anaphylaxis and requires premedication with antihistamines and steroids.

66
New cards

Xarelto in AFib

Rivaroxaban dosed at 20mg20\,mg daily with the evening meal for patients with CrCl>50mL/minCrCl > 50\,mL/min to maximize bioavailability.

67
New cards

Secondary hyperparathyroidism

A CKD complication triggered by hyperphosphatemia and vitamin D deficiency leading to hypocalcemia and increased PTHPTH.

68
New cards

Doxercalciferol

An active vitamin D analog used in ESRDESRD when the kidneys are unable to activate vitamin D.

69
New cards

CYP3A4 inhibitors

Substances that can increase drug levels, including Ritonavir, Diflucan, and Grapefruit.

70
New cards

Parenteral Nutrition Osmolarity Formula

mOsmol/L=[Weight (g/L)MW (g/mole)]×particles×1,000mOsmol/L = [\frac{\text{Weight (g/L)}}{\text{MW (g/mole)}}] \times \text{particles} \times 1,000.

71
New cards

D5/NS Osmolarity

The calculated value for an IV fluid containing 5% dextrose5\%\text{ dextrose} and 0.9% sodium chloride0.9\%\text{ sodium chloride} is 560mOsmol/L560\,mOsmol/L.

72
New cards

Loop diuretic equivalence

40mg40\,mg of oral furosemide provides an equivalent diuretic effect to 20mg20\,mg of torsemide.

73
New cards

Norepinephrine MOA

A vasopressor used to maintain blood pressure in septic shock primarily through alpha-1 receptor agonism.

74
New cards

Phentolamine

An alpha-blocker administered to treat the extravasation of vasopressors.

75
New cards

Complera

A combination antiretroviral product containing Emtricitabine, Tenofovir disoproxil fumarate, and Rilpivirine.

76
New cards

Nasacort Allergy 24-HR

An intranasal allergy spray containing the active ingredient triamcinolone.

77
New cards

Valganciclovir

An antiviral for cytomegalovirus colitis that requires dose adjustments if CrClCrCl is below 60mL/min60\,mL/min.

78
New cards

Cetuximab

An EGFREGFR inhibitor monoclonal antibody used for metastatic colorectal adenocarcinoma.

79
New cards

KRAS wild-type

The laboratory result required to confirm that cetuximab will be effective in treating metastatic colorectal cancer.

80
New cards

HLA-B*1502

A genetic allele that should be negative to reduce the risk of serious skin reactions with the use of carbamazepine.

81
New cards

IV Iron Boxed Warning

Fatal anaphylaxis warnings associated specifically with iron dextran and ferumoxytol (FerahemeFeraheme).

82
New cards

Feraheme Monitoring

Monitoring patients for signs of hypersensitivity reactions for at least 3030 minutes after the iron infusion.

83
New cards

p-value significance

A result is statistically significant if the p-value calculated by a statistical test is less than the predetermined alpha.

84
New cards

Confidence Interval ratio significance

A result for an Odds Ratio (OROR) is statistically significant if the interval does not include 11.

85
New cards

Ezetimibe MOA

Decreases low-density lipoprotein cholesterol by inhibiting the absorption of cholesterol in the small intestine.

86
New cards

PCSK9 inhibitors

Monoclonal antibodies like alirocumab that prevent the degradation of LDLLDL receptors.

87
New cards

Statins MOA

Inhibition of HMG-CoA reductase at the rate-limiting step of cholesterol synthesis.

88
New cards

Cyclophosphamide oral liquid BUD

A beyond-use date of 5656 days is appropriate when stored in a refrigerator.

89
New cards

Hypothyroidism Characteristics

Elevated TSHTSH level, low free T4T4, and symptoms such as weight gain and fatigue.

90
New cards

Levothyroxine

The treatment of choice for overt primary hypothyroidism that provides synthetic T4T4 replacement.